Roger Sidhu
Algemeen Directeur bij Treadwell Therapeutics, Inc.
Profiel
Roger Sidhu is currently the Chief Executive Officer at Treadwell Therapeutics, Inc. He previously held positions as the Global Product GM-Translational Sciences at Amgen, Inc. from 2016 to 2017, Chief Medical Officer, Executive VP & Head-R&D at Roivant Sciences Ltd.
from 2020 to 2021, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2020, Chief Medical Officer at Cell Design Labs, Inc. from 2017 to 2018, and Chief Medical Officer at Eterna Therapeutics, Inc. from 2021 to 2023.
Dr. Sidhu obtained a doctorate degree from Queen's University and an undergraduate degree from the University of Alberta.
Actieve functies van Roger Sidhu
| Bedrijven | Functie | Begin |
|---|---|---|
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Algemeen Directeur | 08-12-2023 |
Eerdere bekende functies van Roger Sidhu
| Bedrijven | Functie | Einde |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 31-01-2023 |
| ROIVANT SCIENCES LTD. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
| KITE PHARMA INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Roger Sidhu
| Queen's University | Doctorate Degree |
| University of Alberta | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| ETERNA THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Health Technology |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Health Technology |